Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.
Hesdorffer C, Ayello J, Ward M, Kaubisch A, Vahdat L, Balmaceda C, Garrett T, Fetell M, Reiss R, Bank A, Antman K. Hesdorffer C, et al. Among authors: vahdat l. J Clin Oncol. 1998 Jan;16(1):165-72. doi: 10.1200/JCO.1998.16.1.165. J Clin Oncol. 1998. PMID: 9440739 Clinical Trial.
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Vahdat LT, Papadopoulos K, Balmaceda C, McGovern T, Dunleavy J, Kaufman E, Fung B, Garrett T, Savage D, Tiersten A, Ayello J, Bagiella E, Heitjan D, Antman K, Hesdorffer C. Vahdat LT, et al. Clin Cancer Res. 1998 Jul;4(7):1689-95. Clin Cancer Res. 1998. PMID: 9676843 Clinical Trial.
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: vahdat lt. Bone Marrow Transplant. 1998 Oct;22(7):661-7. doi: 10.1038/sj.bmt.1701408. Bone Marrow Transplant. 1998. PMID: 9818693
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: vahdat lt. J Neurooncol. 1999 Sep;44(2):155-62. doi: 10.1023/a:1006391619009. J Neurooncol. 1999. PMID: 10619499 Clinical Trial.
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Papadopoulos KP, Ayello J, Reiss RF, Troxel A, Kaufman E, Vahdat LT, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: vahdat lt. J Hematother Stem Cell Res. 1999 Aug;8(4):357-63. doi: 10.1089/152581699320117. J Hematother Stem Cell Res. 1999. PMID: 10634173 Clinical Trial.
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP, Ayello J, Tugulea S, Heitjan DF, Williams C, Reiss RF, Vahdat LT, Suciu-Foca N, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: vahdat lt. J Hematother. 1997 Feb;6(1):61-8. doi: 10.1089/scd.1.1997.6.61. J Hematother. 1997. PMID: 9112219 Clinical Trial.
High-dose therapy for breast cancer.
Vahdat L, Antman K. Vahdat L, et al. Blood Rev. 1995 Sep;9(3):191-200. doi: 10.1016/0268-960x(95)90025-x. Blood Rev. 1995. PMID: 8563521 Free article. Review.
Systemic adjuvant therapy of breast cancer.
Garrett TJ, Vahdat LT, Kinne DW. Garrett TJ, et al. Among authors: vahdat lt. J Surg Oncol. 1997 Feb;64(2):167-72. doi: 10.1002/(sici)1096-9098(199702)64:2<167::aid-jso16>3.0.co;2-3. J Surg Oncol. 1997. PMID: 9047258 Review.
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
Papadopoulos KP, Egorin MJ, Huang M, Troxel AB, Kaufman E, Balmaceda CM, Vahdat LT, Hesdorffer CS. Papadopoulos KP, et al. Among authors: vahdat lt. Cancer Chemother Pharmacol. 2001;47(1):45-50. doi: 10.1007/s002800000193. Cancer Chemother Pharmacol. 2001. PMID: 11221961 Clinical Trial.
159 results